Head & Neck · 2014 · 18 citations · 32 references
MedicineOncologyPathologyCancer GeneticsMolecular OncologyNeoplasiaBenign Thyroid DiseaseThyroid CancerThyroid CytologyThyroid DisordersThyroid Nodule EvaluationThyroid SurgeryBenign DiagnosisMedical Chart ReviewNeedle Aspiration BiopsyPapillary Thyroid Carcinoma CytologyPapillary Thyroid Carcinoma PathologyThyroid Cancer PathologyThyroid Nodule CytologyThyroid Nodule Detection
BACKGROUND: The purpose of this study was to evaluate the diagnostic utility of BRAF mutation testing on thyroid nodules "suspicious for papillary thyroid carcinoma" (PTC) cytology. METHODS: A chart review of patients with fine-needle aspiration (FNA) results "suspicious for PTC" with subsequent thyroidectomy was performed. Corresponding archived FNA slides underwent BRAF mutation testing. RESULTS: Sixty-six patients with FNA "suspicious for PTC" underwent thyroidectomy. Forty-two (63.6%) had PTC diagnosed on final histopathology, whereas 21 (31.8%) had benign findings. Thirty-five patients (83%) with histologically proven PTC underwent total thyroidectomy, whereas 7 (17%) underwent hemithyroidectomy. BRAF mutation was detected in 17 of 49 samples (34.6%) available for testing and had 45.5% sensitivity, 87.5% specificity, 88.2% positive predictive value (PPV), and 43.8% negative predictive value (NPV) for diagnosing PTC. Two of 4 patients (50%) who underwent hemithyroidectomy with subsequent completion thyroidectomy had mutated BRAF detected. CONCLUSION: BRAF testing is a useful adjunct to improve PPV for patients with "suspicious for PTC" cytology.
32
BRAF Mutation in Papillary Thyroid Carcinoma
Yoram Cohen, Mingzhao Xing, Elizabeth Mambo et al. · JNCI Journal of the National Cancer Institute · 2003 · 924 citations · Full text
Zubair Baloch, Virginia A. LiVolsi, Syl L. et al. · Diagnostic Cytopathology · 2008 · 885 citations
Yuri E. Nikiforov, N. Paul Ohori, Steven P. Hodak et al. · The Journal of Clinical Endocrinology & Metabolism · 2011 · 789 citations · Full text